Synopsys Stock Surges 22%, With A 8-Day Winning Spree
Synopsys (SNPS) – a provider of electronic design automation software and IP solutions – hit a 8-day winning streak, with cumulative gains over this period amounting to 22%. The company’s market cap has surged by about $16 Bil over the last 8 days and currently stands at $90 Bil.
Is this an opportunity or a trap? There is not much to fear in SNPS stock given its overall Strong operating performance and financial condition. But given its Very High valuation, the stock appears Relatively Expensive (For details, see Buy or Sell SNPS).
But here is the interesting part. You are reading about this 22% move after it happened. The market has already priced in the news. To catch the next winner before the headlines, you need predictive signals, not notifications. High Quality Portfolio is based on an architecture that includes such signals.
Returns vs S&P 500
- RH Stock: Strong Cash Flow Poised for a Re-Rating?
- Intuitive Surgical Stock at Support Zone – Bargain or Trap?
- Tractor Supply Stock Hits Key Support – Buying Opportunity?
- What Is Happening With Phillips 66 Stock?
- Is T-Mobile US Stock an Under-Analyzed Capital Compounder Opportunity?
- Structural Risks to Watch For AMD Stock Over the Next 6 Months
The following table summarizes the return for SNPS stock vs. the S&P 500 index over different periods, including the current streak:
| Return Period | SNPS | S&P 500 |
|---|---|---|
| 1D | 2.1% | 1.0% |
| 8D (Current Streak) | 21.7% | 4.7% |
| 1M (21D) | 10.4% | 8.5% |
| 3M (63D) | -8.6% | 3.8% |
| YTD 2026 | 1.6% | 4.3% |
| 2025 | -3.2% | 16.4% |
| 2024 | -5.7% | 23.3% |
| 2023 | 61.3% | 24.2% |
Gains and Losses Streaks: S&P 500 Constituents
There are currently 63 S&P constituents with 3 days or more of consecutive gains and 107 constituents with 3 days or more of consecutive losses.
| Consecutive Days | # of Gainers | # of Losers |
|---|---|---|
| 3D | 23 | 74 |
| 4D | 13 | 24 |
| 5D | 15 | 3 |
| 6D | 8 | 4 |
| 7D or more | 4 | 2 |
| Total >=3 D | 63 | 107 |
Key Financials for Synopsys (SNPS)
Last 2 Fiscal Years:
| Metric | FY2024 | FY2025 |
|---|---|---|
| Revenues | $6.1 Bil | $7.1 Bil |
| Operating Income | $1.4 Bil | $914.9 Mil |
| Net Income | $2.3 Bil | $1.3 Bil |
Last 2 Fiscal Quarters:
| Metric | 2025 FQ4 | 2026 FQ1 |
|---|---|---|
| Revenues | $2.3 Bil | $2.4 Bil |
| Operating Income | $121.4 Mil | $321.3 Mil |
| Net Income | $448.7 Mil | $65.0 Mil |
While SNPS stock looks attractive given its winning streak, investing in a single stock without detailed, thorough analysis can be risky. The Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 — the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.